Chromosomal instability predicts metastatic disease in patients with insulinomas

Endocrine-Related Cancer

Volumn 12, Issue 2, 2005, Pages 435-447

  Jonkers, Y M H ^a   Claessen, S M H ^a   Perren, A ^b   Schmid, S ^b   Komminoth, P ^c   Verhofstad, A A ^d   Hofland, L J ^e   De Krijger, R R ^e   Slootweg, P J ^f   Ramaekers, F C S ^a   Speel, E J M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Hospital Baden   (Switzerland)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 14Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 6Q; CHROMOSOME 9Q; COMPARATIVE GENOMIC HYBRIDIZATION; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA CONTENT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; HUMAN TISSUE; INSULINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS TUMOR; POLYMERASE CHAIN REACTION; PREDICTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; CHROMOSOMAL INSTABILITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INSULINOMA; MALE; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; NUCLEIC ACID HYBRIDIZATION; PANCREATIC NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 21244446206     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.00960     Document Type: Article

References (61)

1. Abdollahi A, Pisarcik D, Roberts D, Weinstein J, Cairns P & Hamilton TC 2003 LOT1 (PLAGL1/ZACI), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. Journal of Biological Chemistry 278 6041-6049.
2. Aster JC, Xu L, Karnell FG, Patriub V, Pui JC & Pear WS 2000 Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch-1. Molecular and Cellular Biology 20 7505-7515.
3. Barghorn A, Komminoth P, Bachmann D, Rütimann K, Saremaslani P, Mulatta-Feurer S, Perren A, Roth J, Heitz PU & Speel EJM 2001a Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression. Journal of Pathology 194 451-458.
4. Barghorn A, Speel EJM, Farspour B, Saremaslani P, Schmid S, Perren A, Roth J, Heitz PU & Komminoth P 2001b Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. American Journal of Pathology 158 1903-1911.
5. Baumgärtner AK, Zettl A, Chott A, Ott G, Müller-Hermelink HK & Starostik P 2003 High frequency of genetic aberrations in enteropathy-type T-cell lymphoma. Laboratory Investigation 83 1509-1516.
6. Beghelli S, Pelosi G, Zamboni G, Falconi M, Iacono C, Bordi C & Scarpa A 1998 Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p. Journal of Pathology 186 41-50.
7. Bertolino P, Tong WM, Herrera PL, Casse H, Zhang CX & Wang ZQ 2003 Pancreatic β-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Research 63 4836-4841.
8. Booden MA, Campbell SL & Der CJ 2002 Critical but distinct roles for the pleckstrin homology and cysteine-rich domains as positive modulators of Vav2 signaling and transformation. Molecular and Cellular Biology 22 2487-2497.
9. Böttger T, Seidl C, Seifert JK, Heintz A, Bretz B & Junginger T 1997 Value of quantitative DNA analysis in endocrine tumors of the pancreas. Oncology 54 318-323.
10. Cavallari I, D'agostino DM, Ferro T, Rosato A, Barzon L, Pasquali C, Fogar P, Theodoropoulou M, Esposito G & Boscaro M 2003 In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. Journal of Clinical Endocrinology and Metabolism 88 3893-3901.
11. Chakrabarti R, Srivatsan ES, Wood TF, Eubanks PJ, Ebrahimi SA, Gatti RA, Passaro E Jr & Sawicki MP 1998 Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13. Genes, Chromosomes and Cancer 22 130-137.
12. Chan AO, Kim SG, Bedeir A, Issa JP, Hamilton SR & Rashid A 2003 CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 22 924-934.
13. Chandrasekharappa SC & Teh BT 2003 Functional studies of the MEN1 gene. Journal of Internal Medicine 253 606-615.
14. Chun J & Doherty GM 2001 Pancreatic endocrine tumors. Current Opinion in Oncology 13 52-56.
15. Chung DC, Smith AP, Louis DN, Graeme-Cook F, Warshaw AL & Arnold AA 1997 Novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. Journal of Clinical Investigation 100 404-410.
16. Chung DC, Brown SB, Graeme-Cook F, Tillotson LG, Warshaw AL, Jensen RT & Arnold A 1998 Localisation of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. Cancer Research 58 3706-3711.
17. Cupisti K, Höppner W, Dotzenrath C, Simon D, Berndt I, Röher HD & Goretzki PE 2000 Lack of MEN1 gene mutations in 27 sporadic insulinomas. European Journal of Clinical Investigation 30 325-329.
18. Dannenberg H, Speel EJ, Zhao J, Saremaslani P, van der Harst E, Roth J, Heitz PU, Bonjer HJ, Dinjens WN, Mooi MJ et al. 2000 Losses of chromosome 1p and 3q are early genetic events in the development of sporadic pheochromocytomas. American Journal of Pathology 157 353-359.
19. Davoren PM & Epstein MT 1992 Insulinoma complicating tuberous sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 55 1209-1212.
20. DeAizpurua HJ, Cram DS, Naselli G, Devereux L & Dorow DS 1997 Expression of mixed lineage kinase-1 in pancreatic β-cell lines at different stages of maturation and during embryonic pancreas development. Journal of Biological Chemistry 272 16364-16373.
21. Draviam VM, Xie S & Sorger PK 2004 Chromosome segregation and genomic stability. Current Opinion in Genetics and Development 14 120-125.
22. Ebrahimi SA, Wang EH, Wu A, Schreck RR, Passaro E Jr & Sawicki MP 1999 Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors. Cancer Research 59 311-315.
23. Figueiredo BC, Ribeiro RC, Zambetti G, Haddad B, Pianovsky MD, Pereira RM, DeLacerda L & Sandrini R 2000 Amplification of 9q34 in childhood adrenocortical tumors: a specific feature unrelated to ethnic origin or living conditions. Brazilian Journal of Medical and Biological Research 33 1217-1224.
24. Garcia JL, Tardio JC, Gutierrez NC, Gonzalez MB, Polo JR, Hernandez JM & Menarguez J 2002 Chromosomal imbalances identified by comparative genomic hybridization in sporadic parathyroid adenomas. European Journal of Endocrinology 146 209-213.
25. Goebel SU, Iwamoto M, Raffeld M, Gibril F, Hou W, Serrano J & Jensen RT 2002 HER-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness. Cancer Research 62 3702-3710.
26. Goldman JM & Melo JV 2003 Chronic myeloid leukemia-advances in biology and new approaches to treatment. New England Journal of Medicine 349 1451-1464.
27. Görtz B, Roth J, Krähenmann A, De Krijger RR, Muletta-Feurer S, Rütimann K, Saremaslani P, Speel EJM, Heitz PU & Komminoth P 1999 Mutations and allelic deletions of the MEN 1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. American Journal of Pathology 154 429-436.
28. Graeme-Cook F, Bell DA, Flotte TJ, Preffer F, Pastel-Levy C, Nardi G & Compton C 1990 Aneuploidy in pancreatic insulinomas does not predict malignancy. Cancer 66 2365-2368.
29. Gumbs AA, Moore PS, Falconi M, Bassi C, Beghelli S, Modlin I & Scarpa A 2002 Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. Journal of Surgical Oncology 81 45-53.
30. Guo SS, Arora C, Shimoide AT & Sawicki MP 2002 Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors. Molecular and Cellular Endocrinology 190 109-114.
31. Hessman O, Lindberg D, Einarsson A, Lillhager P, Carling T, Grimelius L, Eriksson B, Akerström G, Westin G & Skogseid B 1999 Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN1-associated pancreatic endocrine tumors. Genes, Chromosomes and Cancer 26 258-264.
32. Robert O & Westphall H 2000 Functions of LIM-homeobox genes. Trends in Genetics 16 75-83.
33. Hochwald SN, Zee S, Conlon KC, Colleoni R, Louie O, Brennan MF & Klimstra DS 2002 Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. Journal of Clinical Oncology 20 2633-2642.
34. Knuutila S, Björkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H et al. 1998 DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. American Journal of Pathology 152 1107-1123.
35. Komminoth P, Perren A, Öberg K, Rindi G, Heitz PU & Klöppel G 2004 Insulinoma. In Pathology and Genetics. Tumours of Endocrine Organs, pp 183-186. Eds RA DeLellis, RV Lloyd, PU Heitz & C Eng. Lyon: IARC Press.
36. Leothela PD, Jauch A, Holtgreve-Grez H & Thakker RV 2003 Genetics of neuroendocrine and carcinoid tumours. Endocrine-Related Cancer 10 437-450.
37. Mesnil M 2002 Connexins and cancer. Biology of the Cell 94 493-500.
38. Missiaglia E, Moore PS, Williamson J, Lemoine NR, Falconi M, Zamboni G & Scarpa A 2002 Sex chromosome anomalies in pancreatic endocrine tumors. International Journal of Cancer 98 532-538.
39. Moore PS, Beghelli S, Zamboni G & Scarpa A 2003 Genetic abnormalities in pancreatic cancer. Molecular Cancer 2 7-12.
40. Napolitana G, Majello B & Lania L 2002 Role of cyclin/Cdk9 complex in basal and regulated transcription (review). International Journal of Oncology 21 171-177.
41. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih LM, Vogelstein B & Lengauer C 2002 The role of chromosomal instability in tumor initiation. PNAS 99 16226-16231.
42. Pagotto U, Arzberger T, Theodoropoulou M, Grubler Y, Pantaloni C, Saeger W, Losa M, Journot L, Stalla GK & Spengler D 2000 The expression of the antiproliferative gene ZAC is lost or highly reduced in non-functioning pituitary adenomas. Cancer Research 60 6794-6799.
43. Perren A, Barghorn A, Schmid S, Saremaslani P, Roth J, Heitz PU & Komminoth P 2002 Absence of somatic SDHD mutations in sporadic neuroendocrine tumors and detection of two germline variants in paraganglioma patients. Oncogene 21 7605-7608.
44. Polly P, Danielsson C, Schrader M & Carlberg C 2000 Cyclin C is a primary 1alpha,25-dihydroxyvitamin D(3) responding gene. Journal of Cellular Biochemistry 77 75-81.
45. Ray ME, Wistoow G, Su YA, Meltzer PS & Trent JM 1997 AIM1, a novel non-lens member of the beta-gamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. PNAS 94 3229-3234.
46. Schussheim DH, Skarulis MC, Agarwal SK, Simonds WF, Burns AL, Spiegel AM & Marx SJ 2001 Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends In Endocrinology and Metabolism 12 173-178.
47. Speel EJM, Richter J, Moch H, Egenter C, Saremaslani P, Rütimann K, Zhao J, Barghorn A, Roth J, Heitz PU et al. 1999 Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. American Journal of Pathology 155 1787-1794.
48. Speel EJM, Scheidweiler AF, Zhao J, Matter C, Saremaslani P, Roth J, Heitz PU & Komminoth P 2001 Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9q34 is an early event in insulinomas. Cancer Research 61 5186-5192.
49. Speel EJM, Meier D, Zhao J, Matter C, Muletta-Feurer S, Perren A, Saremaslani P, Schuuring ED, Roth J & Heitz P 2002 Chromosome 11q losses in sporadic endocrine pancreatic and neuroendocrine tumors indicate the presence of another tumor suppressor gene telomeric of MEN1. Proceedings of the AACR 43 636.
50. Stumpf E, Aalto Y, Höög A, Kjellman M, Otonkoski T, Knuutila S & Andersson LC 2000 Chromosomal alterations in human pancreatic endocrine tumors. Genes, Chromosomes and Cancer 29 83-87.
51. Terris B, Meddeb M, Marchio A, Danglot G, Fléjou JF, Belghiti J, Ruszniewsky P & Bernheim A 1998 Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system. Genes, Chromosomes and Cancer 22 50-56.
52. Tönnies H, Toliat MR, Ramel C, Pape UF, Neitzel H, Berger W & Wiedenmann B 2001 Analysis of sporadic neuroendocrine tumors of the enteropancreatic system by comparative genomic hybridization. Gut 48 536-541.
53. Vogelstein B & Kinzler KW 2004 Cancer genes and the pathways they control. Nature Medicine 10 789-799.
54. Warren C, James LA, Ramsden RT, Wallace A, Baser ME, Varley JM & Evans DG 2003 Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridization. Journal of Medical Genetics 40 802-806.
55. Wessels PH, Twijnstra A, Kubat B, Ummelen MIJ, Claessen SMH, Sciot R, Merlo A, Ramaekers FCS, Speel EJM & Hopman AHN 2004 10q25.3 (DMBT1) copy number changes in astrocytoma grades 11 and IV. Genes, Chromosomes and Cancer 39 22-28.
56. Wild A, Langer P, Celik I, Chaloupka B & Bartsch DK 2002 Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions. European Journal of Endocrinology 147 507-513.
57. Yang Y, Gil M, Byun SM, Choi I, Pyun KH & Ha H 1996 Transforming growth factor-beta 1 inhibits human keratinocyte proliferation by upregulation of a receptor-type tyrosine phosphatase R-PTP-kappa gene expression. Biochemical and Biophysical Research Communications 228 807-812.
58. Yong L, Corradetti MN, Inoki K & Guan KL 2004 TSC2: filling the GAP in the mTOR signalling pathway. Trends in Biochemical Sciences 29 32-38.
59. Zhao J, Moch H, Scheidweiler AF, Baer A, Schäffer AA, Speel EJM, Roth J, Heitz PU & Komminoth P 2001 Genomic imbalances in the progression of endocrine pancreatic tumors. Genes, Chromosomes and Cancer 32 364-372.
60. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park WS, Agarwal SK, Debelenko LV, Kester M et al. 1997 Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Research 57 4682-4686.
61. Zhuang Z, Park WS, Pack S, Schmidt L, Vortmeyer AO, Pak E, Pham T, Weil RJ, Candidus S, Lubensky IA et al. 1998 Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nature Genetics 20 66-69.